Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RAMBOH-1 talarozole proof-of-concept study in thumb-base hand osteoarthritis
ISRCTN16717773Phase 2Completed
- Sponsor
- University of Oxford
- Start
- Jan 2024
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, double-blind trial in hand osteoarthritis and Rhizarthrosis comparing talarozole with placebo (2 arms). Primary endpoint: Difference in mean cartilage expression of predefined inflammatory gene mRNA levels. Started Jan 2024; status: completed.
02
Drugs
talarozole
03
Conditions
hand osteoarthritisRhizarthrosis
Beyond the preview
Go deeper on ISRCTN16717773.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN16717773.